Pure NMN 99%

NMN (nicotinamide mononucleotide) is a direct precursor to NAD⁺, a coenzyme central to energy and cellular function. NAD⁺ levels decline with age, and NMN supplementation has shown great promise in restoring them. NMN is most often chosen for:

• Cellular energy — supports the body’s production of NAD⁺, essential for energy metabolism.
  
• Healthy ageing — helps maintain mitochondrial function and DNA repair as NAD⁺ levels naturally fall with age.
  
• Metabolic health — supports normal glucose control and cardiovascular function.
  
• Brain & resilience — contributes to cognitive performance and stress resistance in animal and early human studies.

Take 1 capsule once daily, providing 900 mg NMN. Swallow with water, ideally in the morning to support energy metabolism throughout the day.

Consistent daily use for at least 8–12 weeks is recommended in studies examining NAD⁺ levels, energy, and metabolic outcomes.

Ingredients: Nicotinamide mononucleotide (NMN), vegetarian capsule (HPMC).

Free from: fillers, binders, stabilisers, GMOs, and common allergens.

NMN research has accelerated rapidly in recent years, with both preclinical and human trials showing promising results:

• NAD⁺ restoration & ageing: Early clinical trials show that NMN supplementation raises blood NAD⁺ levels in humans (Yoshino et al., 2021, Science; Irie et al., 2020, Endocr J). Restoring NAD⁺ is seen as a central strategy for supporting healthy ageing.
  
• Metabolic health: A 12-week RCT with 250 mg/day NMN improved insulin sensitivity and muscle glucose uptake in overweight women (Yoshino et al., 2021, Science). Other trials using 300–600 mg/day confirmed increased NAD⁺ levels and metabolic improvements.
  
• Performance & endurance: Animal studies have shown NMN enhances aerobic capacity, muscle function, and recovery by improving mitochondrial efficiency (Mills et al., 2016, Cell Metab). Human trials are now underway.
  
• Neuroprotection: Preclinical evidence shows NMN supports brain energy metabolism and may protect against age-related cognitive decline (Long et al., 2015, Brain Res).
  

Our formula provides 900 mg NMN daily — higher than doses used in most human trials so far, but still well within the safety range and aligned with the exciting trajectory of current research.

Safety: NMN has been well tolerated in human trials up to 1,200 mg/day. No serious side effects have been reported; occasional mild digestive upset is the most common.